Ciplenza 400mg Tablet
By Ciplenza
Rx
10 Tablet in a Strip

Composition
Favipiravir(400mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
July, 2025

liver
Caution should be exercised when using Ciplenza 400mg Tablet in individuals with severe liver disease. It may be necessary to adjust the dosage of Ciplenza 400mg Tablet for these patients. Please consult your doctor for appropriate guidance regarding the use of this medication.

kidney
Ciplenza 400mg Tablet needs caution in severe kidney disease. Dose adjustment might be required. Consult your doctor.

alcohol
Consult your doctor about consuming alcohol with Ciplenza 400mg Tablet.

driving
When taking Ciplenza 400mg Tablet, be cautious while driving. If you notice any symptoms that make it difficult to focus or react, avoid driving. It's unclear if the tablet affects driving ability.

pregnancy
Ciplenza 400mg Tablet should not be used during pregnancy as it can harm the developing baby, based on studies in pregnant women and animals. Seek advice from your doctor.

breastfeeding
Ciplenza 400mg Tablet is not safe to use while breastfeeding as it may harm the baby. There is a risk of toxicity to the baby when using this medication during breastfeeding.
Habit Forming | No |
Chemical Class | Pyrazinecarboxamide derivative |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹750
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024